Celsion Corp. (CLSN) Misses Q2 EPS by 6c

Celsion Corp. (NASDAQ: CLSN) reported Q2 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $125 thousand versus the consensus estimate of $130 thousand.

For earnings history and earnings-related data on Celsion Corp. (CLSN) click here.

You May Also Be Interested In

• Midday movers: Novavax, Nvidia, Sweetgreen rise; Moderna, Yelp fall
• Novavax (NVAX) stock soars 120% as Sanofi deal 'kicks off a new chapter'
• Cassava Sciences (SAVA) Reports Q1, Provides Updates on Phase 3 Trials of Simufilam